Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection | MicrobiomeTrials← Back to trialsNCT04350138
Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2020-12-29Est. Completion: 2026-02-18
Enrollment target: 2,606 participants Locations- University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States
- UCLA Clinical AIDS Research and Education (CARE) Center, Los Angeles, California, United States
- SFDPH Bridge HIV Center, San Francisco, California, United States
- Emory University School of Medicine - The Ponce de Leon Center, Atlanta, Georgia, United States
- Emory University Hospital Midtown - Emory Clinic Infectious Diseases, Atlanta, Georgia, United States
- University of Illinois at Chicago College of Medicine - Division of Infectious Diseases, Chicago, Illinois, United States
- LSU - CrescentCare Sexual Health Center, New Orleans, Louisiana, United States
- Walter Reed National Military Medical Center, Bethesda, Maryland, United States
- Harlem Prevention Center, Columbia University, Mailman School of Public Health, New York, New York, United States
- University of Pennsylvania HIV/AIDS Prevention Research Division, Philadelphia, Pennsylvania, United States
- Malawi Clinical Research Site, Lilongwe, Lilongwe, Central Region, Malawi
- The Thai Red Cross AIDS Research Centre, Bangkok, Thailand
- Armed Forces Research Institute of Medical Sciences - Royal Thai Army Clinical Research Center, Bangkok, Thailand
Other microbiome trials you might be interested in
Bacterial VaginosisVaginal MicrobiomeChlamydia Trachomatis InfectionNeisseria Gonorrheae InfectionTrichomonas Vaginitis
HIV remains a global pandemic with 37 million infected. In western Kenya, 16% of women in the general population and 29%…
Chicago, United StatesEst. completion Jul 31, 2026
Sexually Transmitted InfectionsGayPre Exposure Prophylaxis
The goal of this observational study is to learn about awareness around PrEP use and adherence, condom use, sexual risk-…
San Diego, United StatesEst. completion Nov 2026